In a new graphic, we explore three key elements at the interface of the biopharmaceutical industry and some of its key partners – The National Institutes of Health (NIH) and academia – that help keep the United States the global leader in advancing biomedical innovation.
For details: https://catalyst.phrma.org/new-graphic-public-private-collaboration-fuels-the-u.s.-biopharmaceutical-ecosystem